KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

Research output: Contribution to journal › Journal article › Research › peer-review

Documents

  • 1527.full

    Final published version, 4.7 MB, PDF document

  • Simone Ferrero
  • Davide Rossi
  • Andrea Rinaldi
  • Alessio Bruscaggin
  • Valeria Spina
  • Christian W. Eskelund
  • Andrea Evangelista
  • Riccardo Moia
  • Ivo Kwee
  • Christina Dahl
  • Alice Di Rocco
  • Vittorio Stefoni
  • Fary Diop
  • Chiara Favini
  • Paola Ghione
  • Abdurraouf Mokhtar Mahmoud
  • Mattia Schipani
  • Arne Kolstad
  • Daniela Barbero
  • Domenico Novero
  • Marco Paulli
  • Alberto Zamò
  • Mats Jerkeman
  • Maria Gomez Da Silva
  • Armando Santoro
  • Annalia Molinari
  • Andres Ferreri
  • Andrea Piccin
  • Sergio Cortelazzo
  • Francesco Bertoni
  • Marco Ladetto
  • Gianluca Gaidano
Original languageEnglish
JournalHaematologica
Volume105
Issue number6
Pages (from-to)1604-1612
ISSN0390-6078
DOIs
Publication statusPublished - 2020

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 237656148